Kenvue KVUE
Kenvue is a consumer goods company that markets health and personal care brands (such as Tylenol, Neutrogena, and Listerine) through pharmacies, supermarkets, and digital channels. Kenvue shows solid financial health (6.15) and acceptable business quality (6.94), with an operating margin of 19.42% and an ROIC of 15.61%, although its high payout ratio of 97.65% limits room to grow the dividend.
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
Kenvue is a consumer goods company that markets health and personal care brands (such as Tylenol, Neutrogena, and Listerine) through pharmacies, supermarkets, and digital channels. Kenvue shows solid financial health (6.15) and acceptable business quality (6.94), with an operating margin of 19.42% and an ROIC of 15.61%, although its high payout ratio of 97.65% limits room to grow the dividend.
Score by category
| Category | Score |
|---|---|
| Financial health | 6.2 |
| Quality / Moat | 6.9 |
| Valuation | 6.3 |
| Growth | 5.5 |
| Dividend | 5.7 |
| Momentum | 7.2 |
| Risk & Context | 8.7 |
OVERALL SCORE: 6.7/10
Context and risks
No specific regulatory, geopolitical, or business model risks for Kenvue beyond those already reflected in the base risk. The company operates in the defensive consumer sector, with limited exposure to current macro factors.
News considered in the analysis
- Kimberly Clark (KMB) Lines Up Assets for $40 Billion Deal Review — La revisión de activos de 40 mil millones de dólares de Kimberly-Clark podría implicar la venta de su participación en Kenvue, lo que podría desbloquear valor para los accionistas de KVUE.
- PG vs. KMB: Bigger Yield Isn’t Everything. Here’s Which Stock Truly Delivers for Retirees — Comparación genérica entre PG y KMB sin información específica sobre KVUE.
- Kimberly-Clark’s 54-Year Dividend Streak Masks a Troubling Cash Flow Problem — Artículo sobre el flujo de caja de KMB, no de KVUE.
- 5 Beaten-Down Dividend Kings Ready to Roar Back in 2027 (One Yields Over 5%) — Lista genérica de acciones con dividendos, sin información específica sobre KVUE.
- Kenvue Inc's Dividend Analysis — Análisis de dividendo de Kenvue, sin información nueva o material.
Verdict: Hold positions, watching cash flow trends and the potential sale of Kimberly-Clark's stake.
Main risk: The high payout ratio (97.65%) could limit Kenvue's ability to reinvest for growth or maintain the dividend if cash flow weakens.
Other Consumer Defensive companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →